Position in JNJ
as of Jun 30, 2026
· filed Jul 14, 2026
Position Value
$1,081,912
+$40,598 QoQ
Shares Held
4,260
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
1.06%
of 13F equity value
Holder Rank
#2,943
of 4,664 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Nautilus Advisors LLC holds $5,916,229 across 6 Drug Manufacturers - General names. JNJ ranks #2 (18.3% of the industry book) .
All Filings in JNJ
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,081,912 | 4,260 | Shares | Sole | 2026-07-14 | |
| 2026-03-31 | $1,041,314 | 4,260 | Shares | Sole | 2026-04-17 | |
| 2025-12-31 | $900,232 | 4,350 | Shares | Sole | 2026-01-22 | |
| 2025-09-30 | $824,933 | 4,449 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $703,108 | 4,603 | Shares | Sole | 2025-08-26 | |
| 2025-03-31 | $769,165 | 4,638 | Shares | Sole | 2025-08-26 | |
| 2024-12-31 | $670,747 | 4,638 | Shares | Sole | 2025-08-26 | |
| No filing history on record for this holder in this stock. | ||||||